Reed Hastings Says Big Tech Should Get Used to Being Hated — Like Big Pharma

Reed Hastings, former Netflix co-CEO, believes the tech industry's growing unpopularity is unavoidable and comparable to the public perception of Big Pharma. In recent remarks, Hastings drew a direct parallel between the two sectors, suggesting that as technology becomes more embedded in daily life, scrutiny and resentment will naturally follow. He argues that just as pharmaceutical companies are often vilified despite their life-saving innovations, tech giants should brace for similar treatment. Hastings' perspective comes at a time when major tech companies face increasing criticism over issues like data privacy, market dominance, and societal impact. By invoking Big Pharma—a sector long accustomed to public distrust—he implies that tech leaders must accept hostility as part of operating at scale. This stance reflects a broader debate about whether tech's reputational decline is a temporary backlash or a permanent shift. The comparison is striking because both industries deliver transformative benefits yet remain targets of anger. Hastings, who led Netflix through its rise to global dominance, knows firsthand how quickly public sentiment can turn. His remarks suggest that tech executives should stop trying to win popularity contests and instead focus on long-term resilience. As regulatory pressure mounts and public trust erodes, Hastings' warning may signal a new era of realism for Silicon Valley. The question is whether tech can learn to live with being hated—or find a way to change the narrative.